Neuro-Oncology Reviews




Volume 22 Number 10
31 May 2020




Home > Publications > Neuro-Oncology Reviews > Volume 22, Year 2020 > Number 10, 31 May






Broekx S, Weyns F, De Vleeschouwer S.
5-Aminolevulinic acid for recurrent malignant gliomas: A systematic review.
Clin Neurol Neurosurg. 2020 May 16;195:105913. doi: 10.1016/j.clineuro.2020.105913. PMID: 32447151. Review. ˍ




Hassn Mesrati M, Behrooz AB, Y Abuhamad A, Syahir A.
Understanding Glioblastoma Biomarkers: Knocking a Mountain with a Hammer.
Cells. 2020 May 16;9(5):E1236. doi: 10.3390/cells9051236. PMID: 32429463. Review. ˍ




Blue R, Miranda SP, Gu BJ, Chen HI.
A Primer on Human Brain Organoids for the Neurosurgeon.
Neurosurgery. 2020 May 18;87(4):620-629. doi: 10.1093/neuros/nyaa171. PMID: 32421821. Continuing education. ˍ




Li L, Wang Y, Li Y, Fang S, Jiang T.
Role of molecular biomarkers in glioma resection: a systematic review.
Chin Neurosurg J. 2020 May 18;6:18. doi: 10.1186/s41016-020-00198-x. PMID: 32922947. Review. ˍ




Everett R, Flores KB, Henscheid N, Lagergren J, Larripa K, Li D, Nardini JT, Nguyen PTT, Pitman EB, Rutter EM.
A tutorial review of mathematical techniques for quantifying tumor heterogeneity.
Math Biosci Eng. 2020 May 19;17(4):3660-3709
. doi: 10.3934/mbe.2020207. PMID: 32987550. Review. ˍ




Stocksdale B, Nagpal S, Hixson JD, Johnson DR, Rai P, Shivaprasad A, Tremont-Lukats IW.
Neuro-Oncology Practice Clinical Debate: long-term antiepileptic drug prophylaxis in patients with glioma.
Neurooncol Pract. 2020 May 20;7(6):583-588
. doi: 10.1093/nop/npaa026. PMID: 33312673. Review. ˍ




Khan L, Soliman H, Sahgal A, Perry J, Xu W, Tsao MN.
External beam radiation dose escalation for high grade glioma.
Cochrane Database Syst Rev. 2020 May 21;5:CD011475. doi: 10.1002/14651858.CD011475.pub3. PMID: 32437039. Review. ˍ




Montemurro N, Anania Y, Cagnazzo F, Perrini P.
Survival outcomes in patients with recurrent glioblastoma treated with Laser Interstitial Thermal Therapy (LITT): A systematic review.
Clin Neurol Neurosurg. 2020 May 21;195:105942. doi: 10.1016/j.clineuro.2020.105942. PMID: 32470780. Review. ˍ




Brosseau JP, Liao CP, Le LQ.
Translating current basic research into future therapies for neurofibromatosis type 1.
Br J Cancer. 2020 May 22;10.1038/s41416-020-0903-x. doi: 10.1038/s41416-020-0903-x. PMID: 32439933. Review. ˍ




Daggubati LC, Eichberg DG, Ivan ME, Hanft S, Mansouri A, Komotar RJ, D'Amico RS, Zacharia BE.
Telemedicine for Outpatient Neurosurgical Oncology Care: Lessons Learned for the Future During the COVID-19 Pandemic.
World Neurosurg. 2020 May 22;139:e859-e863. doi: 10.1016/j.wneu.2020.05.140. PMID: 32450309. Review. ˍ




Feldman AZ, Jennings LJ, Wadhwani NR, Brat DJ, Horbinski CM.
The Essentials of Molecular Testing in CNS Tumors: What to Order and How to Integrate Results.
Curr Neurol Neurosci Rep. 2020 May 22;20(7):23. doi: 10.1007/s11910-020-01041-7. PMID: 32445025. Review. ˍ




Liu EK, Sulman EP, Wen PY, Kurz SC.
Novel Therapies for Glioblastoma.
Curr Neurol Neurosci Rep. 2020 May 22;20(7):19. doi: 10.1007/s11910-020-01042-6. PMID: 32445058. Review. ˍ



*

Lu VM, Pendleton C, Brown DA, Lakomkin N, Cho S, Miller KJ, Daniels DJ.
Shaping Our Understanding of Medulloblastoma: A Bibliometric Analysis of the 100 Most Cited Articles.
Clin Neurol Neurosurg. 2020 May 23
;194:105895. doi: 10.1016/j.clineuro.2020.105895. PMID: 32497953. Bibliometric analysis. ˍ




Nayak N, Kumar A.
Cerebellar hemangioblastoma during pregnancy: Management options and review of literature.
Surg Neurol Int. 2020 May 23;11:123. doi: 10.25259/SNI_203_2020. PMID: 32494398. Case report, Review. ˍ




Yan G, Wang Y, Chen J, Zheng W, Liu C, Chen S, Wang L, Luo J, Li Z.
Advances in drug development for targeted therapies for glioblastoma.
Med Res Rev. 2020 May 23;10.1002/med.21676. doi: 10.1002/med.21676. PMID: 32445532. Review. ˍ




Bhattacharya D, Pomeroy SL, Pomeranz Krummel DA, Sengupta S.
Epigenetics and survivorship in pediatric brain tumor patients.
J Neurooncol. 2020 May 25;150(1):77-83. doi: 10.1007/s11060-020-03535-3. PMID: 32451770. Review. ˍ




Han W, Shi J, Cao J, Dong B, Guan W.
Current advances of long non-coding RNAs mediated by wnt signaling in glioma.
Pathol Res Pract. 2020 May 25;216(8):153008. doi: 10.1016/j.prp.2020.153008. PMID: 32703485. Review. ˍ




Kraus TFJ, Machegger L, Pöppe J, Zellinger B, Dovjak E, Schlicker HU, Schwartz C, Ladisich B, Spendel M, Kral M, Reinhardt A, Winkler PA, Sotlar K.
Diffuse midline glioma of the cervical spinal cord with H3 K27M genotype phenotypically mimicking anaplastic ganglioglioma: a case report and review of the literature.
Brain Tumor Pathol. 2020 May 25;37(3):89-94. doi: 10.1007/s10014-020-00365-z. PMID: 32451719. Case report, Review. ˍ




Muster V, Gary T.
Incidence, Therapy, and Bleeding Risk-Cancer- Associated Thrombosis in Patients with Glioblastoma.
Cancers (Basel). 2020 May 26;12(6):E1354. doi: 10.3390/cancers12061354. PMID: 32466430. Review. ˍ




Pinto G, Brou C, Zurzolo C.
Tunneling Nanotubes: The Fuel of Tumor Progression?
Trends Cancer. 2020 May 26;6(10):874-888. doi: 10.1016/j.trecan.2020.04.012. PMID: 32471688. Review. ˍ




Wang Y, Feng Y.
The efficacy and safety of radiotherapy with adjuvant temozolomide for glioblastoma: A meta-analysis of randomized controlled studies.
Clin Neurol Neurosurg. 2020 May 26;196:105890. doi: 10.1016/j.clineuro.2020.105890. PMID: 32623215. Review, Meta-analysis. ˍ



*

Brown JM.
Radiation Damage to Tumor Vasculature Initiates a Program that Promotes Tumor Recurrences.
Int J Radiat Oncol Biol Phys. 2020 May 27;108(3):734-744. doi: 10.1016/j.ijrobp.2020.05.028. PMID: 32473180. Review. ˍ




Laneve P, Caffarelli E.
The Non-coding Side of Medulloblastoma.
Front Cell Dev Biol. 2020 May 27;8:275. doi: 10.3389/fcell.2020.00275. PMID: 32528946. Review. ˍ




Cohen KJ et al., PDQ Pediatric Treatment Editorial Board.
Childhood Medulloblastoma and Other Central Nervous System Embryonal Tumors Treatment (PDQ®): Health Professional Version.
PDQ Cancer Inf Summ. 2020 May 28. NCBI Bookshelf ID: NBK65981. PMID: 26389418. Review. ˍ




Arbab AS, Ali MM.
Glioblastoma: Targeting Angiogenesis and Tyrosine Kinase Pathways.
Nov Approaches Cancer Study. 2020 May 29;4(5):398-401
. PMID: 32924014. Review. ˍ




Chang J, Wang Y, Guo R, Guo X, Lu Y, Ma W, Wang R.
The effect of operations in patients with recurrent diffuse low-grade glioma: A qualitative systematic review.
Clin Neurol Neurosurg. 2020 May 29;196:105973. doi: 10.1016/j.clineuro.2020.105973. PMID: 32610264. Review. ˍ




Cho SJ, Kim HS, Suh CH, Park JE.
Radiological Recurrence Patterns after Bevacizumab Treatment of Recurrent High-Grade Glioma: A Systematic Review and Meta-Analysis.
Korean J Radiol. 2020 May 29;21(7):908-918. doi: 10.3348/kjr.2019.0898. PMID: 32524791. Review, Meta-analysis. ˍ




Quartuccio N, Laudicella R, Vento A, Pignata S, Mattoli MV, Filice R, Comis AD, Arnone A, Baldari S, Cabria M, Cistaro A.
The Additional Value of 18F-FDG PET and MRI in Patients with Glioma: A Review of the Literature from 2015 to 2020.
Diagnostics (Basel). 2020 May 29;10(6):357. doi: 10.3390/diagnostics10060357. PMID: 32486075. Review. ˍ




Wang H, Zhou Y, Li L, Hou W, Ma X, Tian R.
Current status and quality of radiomics studies in lymphoma: a systematic review.
Eur Radiol. 2020 May 29;30(11):6228-6240. doi: 10.1007/s00330-020-06927-1. PMID: 32472274. Review. ˍ




Lynes JP, Nwankwo AK, Sur HP, Sanchez VE, Sarpong KA, Ariyo OI, Dominah GA, Nduom EK.
Biomarkers for immunotherapy for treatment of glioblastoma.
J Immunother Cancer. 2020 May 30;8(1):e000348. doi: 10.1136/jitc-2019-000348. PMID: 32474411. Review. ˍ




Young JS, Gogos AJ, Morshed RA, Hervey-Jumper SL, Berger MS.
Molecular characteristics of diffuse lower grade gliomas: what neurosurgeons need to know.
Acta Neurochir (Wien). 2020 May 30;162(8):1929-1939. doi: 10.1007/s00701-020-04426-2. PMID: 32472378. Review. ˍ